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Abstract: Deoxyribozymes or DNAzymes are single-stranded catalytic DNA molecules that are
obtained by combinatorial in vitro selection methods. Initially conceived to function as gene
silencing agents, the scope of DNAzymes has rapidly expanded into diverse fields, including
biosensing, diagnostics, logic gate operations, and the development of novel synthetic and biological
tools. In this review, an overview of all the different chemical reactions catalyzed by DNAzymes
is given with an emphasis on RNA cleavage and the use of non-nucleosidic substrates. The use
of modified nucleoside triphosphates (dN*TPs) to expand the chemical space to be explored in
selection experiments and ultimately to generate DNAzymes with an expanded chemical repertoire
is also highlighted.
Keywords: SELEX; DNAzymes; chemically modified nucleic acids; functional nucleic acids;
biosensors; therapeutic nucleic acids
1. Introduction
For a long time DNA was thought to be the repository of genetic information, serving solely
as the blueprint of life. However, due its inherent structural properties, DNA and chemically
modified analogs have advanced as warhorses in multiple applications, including the construction
of nanomaterials [1,2], the development of therapeutic agents [3,4], the creation of diagnostic tools
and sensors [5–7], and the design of logic gates and computation circuits [8–11]. Paralleling
these developments, the chemical functions of DNA have been explored beyond its double helical
nature and culminated in the isolation of potent aptamers, i.e., single-stranded oligonucleotides that
bind to specific targets with high affinity and selectivity and that are often considered as being
the chemical equivalent of antibodies [12–15]. Indeed, the advent of the Systematic Evolution of
Ligands by EXponential enrichment (SELEX) technique and related combinatorial methods of in vitro
selection [16], has propelled the development of aptamers for a broad range of targets.
Interestingly, the folding properties and inherent chirality of the double helical DNA have also
been exploited to develop DNA-based catalysts. Catalytic DNA consists either of: (1) supramolecular
hybrids made of metal complexes and double-helical DNA molecules [17–19] or (2) of single-stranded
DNA sequences (coined DNA enzymes, deoxyribozymes, or DNAzymes) obtained by in vitro
selection [20–22].
While DNAzymes were originally conceived as potential gene silencing agents due to their
capacity to specifically and selectively cleave stretches of mRNA targets [23–25], numerous
DNAzymes catalyzing a broad array of chemical transformations have been isolated, thus expanding
their scope and instating them in the role as true biocatalysts along with ribozymes and proteinaceous
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enzymes. Therefore, this review article provides an overview of the diversity of the chemical
repertoire of DNAzymes and will discuss all the chemical reactions catalyzed by these functional
nucleic acids. Moreover, strategies for improving both the catalytic efficiency and the scope of these
biomolecular catalysts will be highlighted, with a strong emphasis on the use of modified nucleoside
triphosphates (dN*TPs) in selection experiments.
2. DNAzymes as Bond Cleaving Catalysts
Shortly after the advent of SELEX for the generation of aptamers [26–28], this method of
molecular Darwinian evolution was adapted to isolate the first DNAzyme, designed to act as an
artificial ribonuclease [20]. This method is highlighted in Figure 1 and only deviates slightly from the
original protocol devised for the isolation of aptamers. Briefly, the selection process starts with the
generation of an initial population of oligonucleotides bearing fixed-sequence regions at both ends
(for the docking of PCR primers) and a central randomized region, typically N20 or N40 (Figure 1A).
This library—generally containing up to 1016 molecules and generated by PCR or primer extension
reactions with primers containing the scissile units (e.g., RNA nucleotides)—is then immobilized
on a solid support and incubated under the appropriate reaction conditions (Figure 1B,C). Only
the catalytically proficient species will be capable of cleaving their own release from the solid
support (Figure 1C) and will be PCR amplified (Figure 1D) and used in subsequent rounds of
selection [29]. The reaction conditions often involve diverse metal cations including Mg2+ [30,31],
Pb2+ [20], Cd2+ [32], Ln3+ [33–35], UO22+ [36] or small organic molecules such as histidine [37], which
serve as cofactors for the functionality depleted nucleic acid catalysts. The choice of the adequate
reaction buffer is of paramount importance and has a strong influence on the outcome of the selection
experiment. Recently, Lu and coworkers used a minimal buffer containing either 135 or 400 mM Na+,
10 mM citrate, and 1 mM EDTA to isolate an RNA-cleaving DNAzyme that was strictly and solely
dependent on the presence of Na+ [38]. Besides the buffer composition, multiple parameters can
be used to alter the stringency of the selection. For instance, an increase in stringency can involve a
reduction of either the reaction time or the concentration of the cofactor, a variation of the temperature
and ionic strength, an alteration of the amplification or primer extension protocols [29,39–42], or the
inclusion of a splint ligation step [43] or blocking oligonucleotides [32]. The choice of the length of the
random section for the generation of the initial population is another experimental variable that can
have a profound impact on the outcome of selection experiments and no defined and general rules
have yet been established [29,44]. For instance, catalytically more efficient DNA-cleaving DNAzymes
were isolated when shorter randomized domains (N20 or N30) were used in selection experiments
than longer stretches (N50 or N60), while the opposite trend was observed when the initial populations
were challenged to catalyze the tyrosine-RNA nucleopeptide linkage formation [44].
Application of in vitro selection has led to the identification of numerous DNAzymes catalyzing
the scission of ribophosphodiester linkages (Figure 2A). As a matter of fact, a vast majority of the
selected DNAzymes catalyze the hydrolysis of RNA substrates due to the ease of selection and
the potential (in vivo) applications [45]. However, lured by the catalytic prowess of RNA-cleaving
DNAzymes and by the inherent properties of DNA, a rich field of DNAzymes capable of cleaving
various bonds has been developed (Figure 2) [46,47]. Indeed, DNAzymes capable of hydrolyzing
the phosphodiester linkages of DNA (Figure 2B), ester and anilide bonds (Figure 2C), and even a
DNAzyme capable of repairing thymine dimers (Figure 2D) have been isolated. The following section
describes all the different DNAzymes capable of catalyzing bond-scission reactions.
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Figure 1. Overview of the selection scheme for the generation of RNA-cleaving DNAzymes:  
(A) oligonucleotides containing fixed-sequence regions (shown in blue) for the docking of the PCR 
primers and a central randomized region (in green) obtained by solid-phase synthesis, constitute the 
starting point for the generation of a randomized library either by PCR or by primer extension 
reaction. The primers often have biotin residues appended at their 5′-ends to enable immobilization 
of the oligonucleotide population and contain the RNA substrate; (B) the library is immobilized on a 
solid support (e.g., streptavidin-coated magnetic particles) and if necessary, the template strand is 
stripped off by a hydroxide treatment; (C) the immobilized population of oligonucleotides is subjected 
to the reaction conditions, and only the catalytically active species will be separated from the solid 
support and eluted; (D) the eluted sequences are PCR amplified and used in a subsequent round of 
selection. Adapted from reference [15].  
 
Figure 2. Summary of the different reactions catalyzed by bond-cleaving DNAzymes: (A) cleavage of 
ribophosphodiester linkages; (B) scission of deoxyribophosphodiester bonds [48,49]; (C) hydrolysis 
of ester units [50]; (D) photoreactivation of cyclobutane thymine dimers [51]. 
2.1. RNA-Cleaving DNAzymes 
As aforementioned, the first DNAzyme was isolated by in vitro selection by Breaker and Joyce 
in 1994 (Figure 3A) [20]. This early selection experiment involved a substrate containing a single 
embedded ribo(adenosine) nucleotide and the reaction buffer contained 1 mM Pb2+, which was 
deemed to serve as the divalent metal cofactor and promote catalysis by analogy to what had been 
observed in the case of some ribozymes [52,53]. Starting with an initial population consisting of ~1014 
molecules with an N50 randomized stretch, five rounds of in vitro selection led to the isolation of a 
Pb2+-dependent intramolecular (cis) catalyst. This DNAzyme promoted the hydrolysis of the scissile 
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2.1. RNA-Cleaving DNAzymes
As aforementioned, the first DNAzyme was isolated by in vitro selection by Breaker and Joyce
in 1994 (Figure 3A) [20]. This early selection experiment involved a substrate containing a single
embedded ribo(adenosine) nucleotide and the reaction buffer contained 1 mM Pb2+, which was
deemed to serve as the divalent metal cofactor and promote catalysis by analogy to what had
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been observed in the case of some ribozymes [52,53]. Starting with an initial population consisting
of ~1014 molecules with an N50 randomized stretch, five rounds of in vitro selection led to the
isolation of a Pb2+-dependent intramolecular (cis) catalyst. This DNAzyme promoted the hydrolysis
of the scissile linkage with a first-order rate constant (kobs) of 1.4 min´1 [20], which represents an
impressive ~107-fold rate-enhancement compared to the background cleavage of RNA [54]. This
cis-cleaving leadzyme was converted into an intermolecular (trans) catalyst (Figure 3A) that could
cleave the substrate with a catalytic efficiency (kcat/Km) of 5 ˆ 107 min´1¨M´1. Following this
initial discovery, other DNA-based ribophosphodiesterases including Mg2+ and Ca2+-dependent
DNAzymes were isolated by in vitro selection experiments [30,55]. Both these DNA metalloenzymes
cleaved substrates containing a single ribo(adenosine) nucleotide, both in cis and trans, with catalytic
efficiencies lying in the range of 103–104 min´1¨M´1. Subsequently, two of the most proficient
and complete DNAzymes, coined Dz8-17 (Figure 3B) and Dz10-23 (Figure 3C), were isolated by
Santoro and Joyce [31]. These Mg2+-dependent DNAzymes can cleave a broad variety of all-RNA
substrates (Figure 3) with efficiencies approaching kinetic perfection (~109 min´1¨M´1) at high Mg2+
concentrations (~100 mM) [31,56]. While Dz10-23 was shown to be rather tolerant to the nature of
the substrate, cleaving all purine-pyrimidine dinucleotide junctions (R¨Y in Figure 3C with R = A or
G; Y = U or C) [31,56], Dz8-17 was initially thought to be more demanding in terms of sequence
requirements of the substrate, cleaving only a G¨A dinucleotide junction (Figure 3B). However,
reselection of Dz8-17 variants [57] and mutation experiments [58] later revealed that Dz8-17 can be
coerced into cleaving all 16 dinucleotide junctions, albeit with kobs values spanning over five orders
of magnitude.
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Figure 3. Putative schematic representations of the putative secondary structures of RNA-cleaving 
DNAzymes: (A) the first RNA-cleaving Pb2+-dependent DNAzyme to have been isolated by in vitro 
selection [20]; the all-RNA cleaving DNAzymes 8-17 (B) and 10-23 (C) [31]; and (D) the UO22+-dependent 
RNA cleaving DNAzyme EHg0T [59]. The substrates are shown in grey and thin lines and lower case 
letters represent RNA units, while thick lines and upper case letters represent stretches of DNA 
nucleotides. The cleavage sites are indicated by an arrow.  
The catalytic core of Dz8-17 consists of an important G·T wobble pair [31,60], a three-nucleotide 
long stem maintained by Watson-Crick pairs, an AGC trinucleotide loop, and four unpaired residues. 
On the other hand, the 15-nt long catalytic domain of Dz10-23 seems to be devoid of any salient 
structural feature and consists solely of unpaired nucleotides. Both DNAzymes share common 
features, including four highly-conserved residues in the catalytic core, which hints at the possibility 
that Dz10-23 is a structural variant of Dz8-17 [61]. 
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D Azy es: (A) the first RNA-cleaving Pb2+-dependent DNAzyme to have been isolated by
in vitro selection [20]; the all-RNA cleaving DNAzymes 8-17 (B) and 10-23 (C) [31]; and (D) the
UO22+-dependent RNA cleaving DNAzyme EHg0T [59]. The substrates are shown in grey and thin
lines and lower case letters represent RNA units, while thick lines and u per case letters represent
stretches of DNA nucleotides. The cleavage sites are indicated by an arrow.
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The catalytic core of Dz8-17 consists of an important G¨T wobble pair [31,60], a three-nucleotide
long stem maintained by Watson-Crick pairs, an AGC trinucleotide loop, and four unpaired residues.
On the other hand, the 15-nt long catalytic domain of Dz10-23 seems to be devoid of any salient
structural feature and consists solely of unpaired nucleotides. Both DNAzymes share common
features, including four highly-conserved residues in the catalytic core, which hints at the possibility
that Dz10-23 is a structural variant of Dz8-17 [61].
Surprisingly, the Dz8-17 motif has poisoned numerous independent in vitro selection
experiments designed to improve and extend the scope of RNA-cleaving DNAzymes [42,55,60,62–65].
The resurgence of a small catalytic motif in selection experiments, the so-called tyranny of the small
motif [66], may be ascribed to the much higher statistical probability of the presence of multiple
copies of a smaller sequence motif than that of comparatively larger or more complex motifs. Other
factors may also contribute to the recurrence of small motifs including the capacity of smaller motifs
to adopt secondary and tertiary structures, the choice of the conditions chosen in the in vitro selection
experiment, and the ease of replication during PCR or primer extension reactions (especially in the
context of modified dN*TPs) [66–68].
In the absence of a crystal structure of an active DNAzyme [69], insight into the folding
characteristics and the catalytic mechanism have been gathered by FRET analyses [70–74],
mutagenesis and deletion experiments [61,75–78], and biochemical characterization [56,79]. In the
case of Dz8-17, the induced folding preceding the catalytic activity strongly depends on the nature
of the metal cation involved. Indeed, in the presence of Mg2+ and Zn2+, the metal cation induces
a global folding of the enzyme which is then activated for catalysis, thus following an induced
fit mechanism [71]. On the other hand, in the presence of Pb2+, no global folding is observed
and catalysis is initiated by the binding of the divalent metal cation to the binding pocket, thus
following a lock-and-key type of mechanism [71,72]. Conversely, less is known on the folding of
Dz10-23 by the impulse of metal cofactors, but it appears to be similar to that of Dz8-17 triggered
by Mg2+ and Zn2+ [74,80]. Indeed, the folding and catalytic activity seem to be intertwined and
Dz10-23 adopts a compact, triangular pyramidal structure upon addition of Mg2+ [81]. At low
divalent metal concentrations (~0.5 mM), the induced folding is not sufficient to promote efficient
catalysis, which only occurs at higher concentrations (~5 mM) when the DNAzyme is folded in
its compact structure and the flanking arms simultaneously adopt the appropriate orientation for
binding to the substrate [80]. Therefore, it is believed that RNA-cleavage mediated by both Dz8-17
and Dz10-23 follows a mechanism that is similar to that of ribozymes such as the hammerhead
ribozyme (Figure 4) [80,82]. Briefly, folding of the DNAzyme scaffold triggered by the presence of
the divalent metal cofactors allows an adequate positioning of the substrate and the functionalities
involved in the catalytic step. In addition, the M2+ cofactor will also activate the nucleophilic
21-hydroxyl unit flanking the scissile bond by deprotonation and/or coordination [72]. Finally, the
SN2-like nucleophilic attack on the phosphorous center leads to a pentacoordinate intermediate,
which breaks down into the 21,31-cyclic phosphate and the 51-OH products. The 21,31-cyclic phosphate
product is further hydrolyzed to a 21- or 31-phosphate only in the case when Dz8-17 is incubated
with Pb2+ [83].
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Figure 4. RNA-cleavage reaction (shown for Dz8-17) leading to the 2′,3′-cyclic phosphate and the  
5′-OH products and plausible sites of interaction of the M2+ cofactors (directly or via an activated water 
molecule):(a) negative charge stabilization of a non-bridging oxygen atom or general acid catalysis; 
(b) activation of the nucleophilic hydroxyl unit by deprotonation or coordination; (c) stabilization of 
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Figure 4. RNA-cleavage reaction (shown for Dz8-17) leading to the 21,31-cyclic phosphate and
the 51-OH products and plausible sites of interaction of the M2+ cofactors (directly or via an
activated water molecule):(a) negative charge stabilization of a non-bridging oxygen atom or general
acid catalysis; (b) activation of the nucleophilic hydroxyl unit by deprotonation or coordination;
(c) stabilization of the build-up of negative charge on the oxygen atom of the leaving group;
(d) general base catalysis [72,82,84,85]. Scheme adapted from reference [82].
The versatility and catalytic prowess of Dz8-17 and Dz10-23 have propelled these biocatalysts to
the forefront of numerous applications, including their use as therapeutic nucleic acids, biosensors,
and logic gate and circuits [8]. Initially, Dz8-17 and Dz10-23 were conceived as gene silencing
agents and consequently numerous in vivo and in vitro assays have been conducted in order to
evaluate their capacity at operating as gene regulating devices [86–94]. These promising results
along with continuous research efforts to develop in vivo and in vitro experiments have culminated
in the application of two variants of Dz10-23 in clinical trials [95–97]: (i) Dz13 [98] was designed
so as to specifically cleave c-Jun mRNA in order to inhibit the expression of the c-Jun protein
which is expressed in human atherosclerotic lesions. c-Jun is also an archetypical member of the
AP-1 (activator protein 1) protein family, which has been shown to be implicated in tumorigenesis,
particularly in the formation of skin tumors [99]. The gene-silencing capacity of Dz13 was exploited
to treat basal-cell and squamous-cell carcinomas in different mammals including rodents and
monkeys [100]. This animal study was instrumental for the development of the first-in-human phase I
clinical study of a DNAzyme where Dz13 was administered by intratumoral injection to nine patients
suffering from basal-cell carcinoma [96]. The level of c-Jun expression was reduced in all patients
and three out of nine patients showed a significant decrease in tumour depth; (ii) a more recent
phase IIa clinical trial made use of a variant of Dz10-23 coined hgd40 to treat patients suffering from
allergen-induced asthma [97]. The use of a therapeutic oligonucleotide for the treatment of airway
diseases might seem slightly counterintuitive, but the downregulation of the GATA-3 transcription
factor represents an alluring strategy for directly interfering with the disease. Indeed, GATA-3 is
the master transcription factor for the differentiation of type T-helper cells type 0 (Th0) to Th2
cells following allergen exposure which is a key step in allergic bronchial asthma since the Th2
cells mediate the production of cytokines such as interleukines IL-4, -5, and -13 which then trigger
the immune response [101,102]. The hgd40 DNAzyme was obtained after an in vitro screening of
70 different species containing the catalytic motif of Dz10-23 and randomized binding arms in
order to ensure selective recognition of the mRNA target. This DNAzyme was then shown in
an in vivo preclinical trial to selectively hydrolyze the GATA-3 mRNA in vitro and to inhibit the
inflammation and mucus production in mice [103]. Also, the administration of fluorescently- and
radioactively-labelled hgd40 was utilized to investigate the biodistribution of the DNAzyme in mice,
rats, and dogs [104]. Following these preclinical studies, treatment of patients with hgd40 (10 mg per
once-daily inhalation) led to a reduction of the early and late asthmatic responses in 11% and 34% of
20782
Molecules 2015, 20, 20777–20804
the cases, respectively [97]. Thus, DNAzyme hgd40 presents very favorable assets for the treatment
of asthma, but unanswered questions such as the advantage over small molecules still need to be
addressed in future clinical phase II and III trials.
Despite these favorable results and developments, new methods for the increase of the cellular
delivery and serum resistance of therapeutic oligonucleotides are needed. In this context, it was
shown that the conjugation of antisense oligonucleotides to gold nanoparticles (NPs) was a valuable
strategy since the resulting complexes displayed a higher affinity for complementary sequences
than the unmodified counterparts, were more amenable to cells, and were capable of efficient gene
knockdown [105]. Recently, Dz10-23 was conjugated to NPs and after fine-tuning of the molecular
density on the particles and assessment of the length of the connecting linker, optimal conditions
were found that support catalysis of these constructs [106]. Importantly, these constructs were then
demonstrated to substantially reduce the expression of the growth differentiation factor 15 (GDF15)
underscoring the usefulness of this approach.
The modus operandi of DNAzyme-mediated gene silencing is still matter of debate: numerous
reports suggest that the active DNAzyme cleaves the relevant mRNA target at multiple locations
causing a disruption of the translation (specific effects) [92,103,106,107], while other hint at
non-specific effects where the DNAzymes prevent gene expression by creating a steric blockade
of the mRNA or elicit RNase H, much like therapeutic antisense oligonucleotides [25,80,108]. The
distinction between both mechanisms is rather difficult since both require binding to the mRNA target
and might depend on the nature and the three-dimensional folding of the mRNA [109].
A multitude of different RNA-cleaving DNAzymes has been crafted with the aim of serving
as biosensors, mainly for the detection of metal contaminants. For instance, a UO22+-dependent
DNAzyme that allows for the detection of only trace amounts of the uranyl contaminant [36], was
additionally converted to a highly efficient sensor for the Hg2+-pollutant (Figure 3D) [59]. However,
this very vast and interesting research avenue has been addressed recently by others and is beyond
the scope of this review [47,110–112].
2.2. DNA-Cleaving DNAzymes
The incentive for the development of DNA-cleaving DNAzymes was spurred by: (i) the need for
artificial DNA nucleases that could act as restriction enzymes, which would represent a very valuable
addition to the armamentarium of tools available in microbiology and drug discovery [113,114];
(ii) precedent in RNA with the in vitro selection of group I intron ribozymes capable of hydrolyzing
ssDNAs [115–117]; (iii) the possibility of expanding the catalytic repertoire of DNAzymes towards
more arduous reactions (t1/2 for the uncatalyzed hydrolysis of RNA is ~4 [118] to 10 [54] years
compared to ~140,000 [118] to 30 million [119] years for DNA); (iv) the question of the hypothetical
presence of naturally occurring DNAzymes [49].
Initial selection experiments resulted in the isolation of catalytic DNAs that promoted the
scission of DNA sequences either via an oxidative mechanism (with Cu2+ in the presence or
absence of ascorbate as cofactors) [120] or by depurination of a deoxyguanosine nucleotide followed
by β-elimination at the resulting abasic site [121], but not through the direct hydrolysis of the
phosphodiester bonds. More recently, the base-excision capacity of catalytic DNAs was exploited
in an in vitro selection experiment to generate a Cu2+/Mn2+-dependent DNAzyme that promotes the
selective oxidative excision of thymine nucleotides (rate for trans-cleavage: kobs = 2.3 ˆ 10´3 min´1)
and thus could be used as a tool for the replacement of single-nucleotide polymorphisms (SNPs) [122].
The cleavage mechanism seems to involve a reaction with molecular oxygen or hydrogen peroxide
along with the reduction of Cu(II) to Cu(I) which is of importance for the catalytic activity [122,123].
The first DNAzyme with DNase activity was discovered serendipitously by Silverman et al. who
set out to explore the possibility of DNA-mediated hydrolysis of peptide bonds [48]. The substrate
employed in this selection experiment consisted of a DNA-tripeptide chimera and the resulting
catalytically active species all hydrolyzed the more robust phosphodiester bonds at various locations,
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rather than any of the more labile peptide linkages (t1/2 for the uncatalyzed hydrolysis of amide
bonds is ~500 years [124]). The most active DNAzyme, 10MD5 (Figure 5A), cleaved at the ATGˆT site
in the presence of both the chimeric and an all-DNA substrate with similar high rates (kobs = 0.033
and 0.045 min´1, respectively) and depended on the simultaneous presence of both Mn2+ and Zn2+
cofactors for activity. DNAzyme 10MD5 truly adopts a hydrolytic mechanism because when the
reaction was carried out in 18OH2, incorporation of 18O in the phosphate unit of the 51-product was
observed, as expected for P-O bond hydrolysis [48].
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Figure 5. Sequences and hypothetical 2D structures of the DNA-cleaving DNAzymes 10MD5 [48] (A) 
and I-R3 [49] (B). 
Despite the remarkable catalytic traits, Dz10MD5 is intolerant to even minute changes in the pH 
of the reaction buffer (a delta pH of 0.2 led to a > 10-fold depletion in rate) and displays a rather poor 
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and I-R3 [49] (B).
Despite the remarkable c talytic traits, Dz10MD5 is intolerant to ven m nute chang s in the pH
of the reaction buffer (a delta pH of 0.2 led to a > 10-fold depletion in rate) and displays a rather poor
substrate tolerance (only substrates containing the ATGˆT cleavage site are recognized) and a strong
necessity to bind the substrate via Watson-Crick base-pairing. Consequently, additional selection
experiments were designed to improve on these negative features. Firstly, a partially randomized
catalytic core of 10MD5 along with a systematic variation of the pH of the reaction buffer composed
the basis of a reselection experiment that led to the identification of Dz9NL27 [125]. This DNAzyme
was capable of cleaving an all-DNA substrate with appreciable rate constants (kobs ~1.5 ˆ 10´3
to 0.02 min´1) over a substantial pH range (from 7.2 to 7.7), albeit at the expense of a lower site
specificity (miscleavage was observed). Secondly, in vitro selection experiments were devised to
investigate on the required length of unpaired nucleotides in the substrates and subsequently to
increase the sequence tolerance of DNA-hydrolyzing DNAzymes [43]. These experiments showed
that substrates containing only a single unpaired nucleotide enabled a strong catalytic activity (e.g.,
one DNAzyme, Dz13PD1, displayed an impressive first-order rate constant of 1.2 min´1), while
longer unpaired sequences led to sluggish catalysts and in the absence of unpaired nucleotides the
catalytic species are coerced to adopt an oxidative mechanism. Also, inclusion of an additional splint
ligation in the selection protocol as well as exploration of all possible combinations of XG unpaired
dinucleotides in the substrate, led to the identification of numerous potent DNAzymes with a large
sequence tolerance and that obligatorily proceeded via a hydrolytic mechanism [43]. Finally, the
cofactor dependence could be reduced to the lone Zn2+ cation by a double nucleotide mutation [126]
or converted to lanthanide cations Ln3+ (particularly Ce3+) by in vitro selection [127].
An interesting approach was adopted by Breaker et al. to isolate new classes of DNA-cleaving
DNAzymes [49]: a circular DNA library consisting of two N50 randomized regions was constructed
by using the ATP-dependent ligase CircLigase™ which mediates the circularization reaction of
51-phosphorylated ssDNAs [128,129]. After incubation of the circular library in a buffer containing
Zn2+ as a cofactor, the products stemming from the hydrolytic reaction are subjected to a second
CircLigase-mediated ligation prior to PCR amplification. The ingenuity of this methodology resides
in the fact that cleavage can occur at any location of the construct, even in the randomized regions,
without loss of any genetic information. Simultaneously, this system also avoids the occurrence of
alternate mechanisms such as depurination or oxidative pathways. After 14 rounds of selection,
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two classes of DNAzymes (coined I and II), differing in size and structural features, were identified
and one particular representative of class I, I-R3 (Figure 5B), displayed an impressive rate constant
(kobs = 1.0 min´1) for the Zn2+-dependent hydrolysis of DNA at one specific location (i.e., the A-A
dinucleotide stretch indicated by the arrow in Figure 5B). Like Dz10MD5 (vide supra), I-R3 was very
sensitive to variations in pH (optimal activity at pH 7.0) and heavily dependent on the presence of
the Zn2+-cofactor, but on the other hand displayed a rather large sequence tolerance at the cleavage
site [49]. Interestingly, I-R3 could be converted into a smaller species capable of multiple turnover
which was recruited to cleave the single-stranded genome of bacteriophage M13. Lastly, the high
activity and the relatively small size of the isolated DNAzymes raised the question of the existence
of similar sequences in natural genomes. Even though several analogous sequences were identified
using bioinformatics algorithms, none of these sequences showed any catalytic activity under cellular
Zn2+ concentrations (~50 µM).
2.3. Other Bond Cleaving DNAzymes
Besides DNA catalysts cleaving P-O bonds of RNA and DNA substrates, examples of
bond-cleaving DNAzymes are relatively scarce. However, notable examples include DNA-mimics
of enzymes such as esterases (Figure 2C) [50], CPD-photolyases (Figure 2D), and phosphatases [51].
DNA photolyases repair DNA lesions caused by exposure to UV-radiation. The most common
type of DNA damage is the formation of cyclobutane pyrimidine dimers (CPD) by a [2+2]
cycloaddition and CPD-photolyases use various catalytic cofactors such as reduced flavin (FADH´)
and light as a source of energy to reverse this reaction [130]. Sen and coworkers set out to isolate DNA
enzymes that could emulate photolyases [51]. To this end, a substrate containing a thymine-thymine
photodimer was synthesized and served as the primer for the generation of a randomized library.
After a negative selection step which involved UV-irradiation in the absence of a cofactor, the
population of DNA molecules was incubated with serotonin and subjected to UV-light irradiation
(>300 nm). Sequences that were repaired in the process could be isolated by gel electrophoresis due
to their lower mobility. Surprisingly, robust self-repairing was observed in the negative selection and
cloning and sequencing of the populations of the 20th selection round revealed that the predominant
species emanating from both selection steps were fundamentally different in terms of sequence
composition. DNAzyme UV1A, which was identified from the negative selection pool, was shortened
by removal of a constant region and the resulting DNAzyme, UV1C, displayed a high catalytic
efficiency (kcat/Km = 7.8 ˆ 106 min´1¨M´1) for the self-repair reaction, which represents a stunning
>104-fold rate enhancement compared to the uncatalyzed reaction. In terms of mechanism, the
formation of a G-quadruplex like structure was thought to act as the light-harvesting photoantenna
involved in the efficient transmission of light to the damaged substrate, in analogy to the mechanism
adopted by CPG-photolyases [131]. In a different report, single substitutions of guanine nucleotides
with the fluorescent analog 6-methylisoxanthopterin (6MI) in the scaffold of DNAzyme UV1C
resulted in a catalytic species that functioned at less damaging higher wavelengths (345 nm) [132].
Indeed, when guanine 23, which is believed not to be involved in the G-quadruplex structure,
was substituted with 6MI (or other chromophores), the catalytic efficiency at 345 nm increased
significantly compared to other mutants or the wild-type UV1C (kobs = 0.32 min´1 vs. ~0.005 min´1).
More recently, substrates containing esters, aliphatic and aromatic amides, and a tripeptide
were subjected to in vitro selection conditions to evolve DNAzymes capable of hydrolyzing these
different bonds [50]. Of these selection experiments, DNAzymes that cleaved ester linkages (with
a maximal rate of kobs = 0.05 min´1) as well as anilides (with a rate constant for single-turnover
of kobs = 3.5 ˆ 10´3 min´1) were generated. Surprisingly, no DNAzyme capable of cleaving
aliphatic amide bonds was isolated. This observation underscores the resilience of DNAzymes to
hydrolyze peptide bonds despite the relative lability of these linkages compared to, for instance,
the sturdy phosphodiester bond of DNA [48]. A similar observation had been made in the case of
ribozymes: a selection experiment designed to identify catalysts capable of hydrolyzing an embedded
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31-NH–C(O)–CH2-51 linkage [133], resulted in a ribozyme that cleaved the DNA phosphodiester bond
located 51-upstream of the amide bond instead of the intended target [134]. This reluctance of nucleic
acid-based catalysts to hydrolyze peptide bonds is often ascribed to the rather depleted chemical
arsenal of nucleic acids, and the inclusion of modified nucleoside triphosphates (dN*TPs) in selection
experiments could represent a means to bypass this shortcoming (vide infra) [135,136].
The research group led by Silverman also selected a DNAzyme, Dz 14WM9 (Figure 6A),
capable of hydrolyzing the monophosphoester bond located on the side-chain of a tyrosine or serine,
themselves embedded in a hexameric peptide substrate [137]. This phosphatase mimic catalyzed the
Zn2+-dependent dephosphorylation under both single-turnover (kobs = 0.19 min´1 on tyrosine and
5.2 ˆ 10´3 min´1 on serine) and multiple-turnover (6 turnovers in 24 h, 15 turnovers in 96 h with an
unbound hexapeptide substrate containing a phosphorylated tyrosine) reaction conditions.
Cyclic peptides are alluring targets in drug discovery due to their increased protease resistance
and higher biological activities compared to their linear counterparts. On the other hand, cyclic
peptides also represent more challenging synthons due to the favored E conformation of amide
bonds which impedes the cyclization of small to medium-sized peptides and the occurrence of
intermolecular reactions that compete with macrocyclization in larger systems [138]. In this context,
a selection experiment was devised to evolve DNAzymes capable of eliminating a phosphate group
on the side-chain of serine. After nine rounds of selection using the same hexapeptide substrate
containing a phosphorylated serine as used in the selection of Dz 14WM9, DNAzyme DhaDz1 was
isolated [139]. This DNAzyme catalyzed the elimination reaction with an appreciable rate constant
(kobs = 4.7 ˆ 10´3 min´1) in the presence of three metal cofactors (Zn2+, Mn2+, and Mg2+) under
single-turnover conditions. Importantly, DhaDz1 was capable of multiple-turnover (6–7 turnovers
in 96 h) with an unbound hexapeptide substrate. DhaDz1 was also used to synthesize an analog of
the cyclic peptide compstatin, a highly selective inhibitor of protein-protein interactions (Figure 6B).
Briefly, the linear peptide precursor containing a phosphorylated serine and a homocysteine, was
subjected to the DhaDz1-mediated elimination reaction (under single-turnover conditions) which led
to the alkene precursor that readily underwent base-induced alkylation by the thiol functionality.Molecules 2015, 20, page–page 
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Figure 6. Reactions catalyzed by P-O and C-O bond breaking DNAzymes. (A) DNAzyme 14WM9 
catalyzes the hydrolysis of phosphomonoesters on amino acid side-chains [137]; (B) DNAzyme DhaDz1 
catalyzes the elimination reaction of a phosphate group of a serine side-chain [139].  
3. DNAzymes Catalyzing Bond Formation 
DNAzymes are emerging members in the field of functional nucleic acids and since the advent 
of the first Pb2+-dependent RNA cleaving DNA catalysts, most research efforts were dedicated to the 
isolation of (RNA) bond-cleaving species due to their potential therapeutic and diagnostic appeal and 
the relative ease of selection. This might explain why only a rather restricted number of bond-forming 
DNAzymes have been evolved, especially when compared to their RNA surrogates. Indeed, ribozymes 
have been evolved to catalyze a variety of bond-forming reactions including C-C bonds [140,141], 
aminoacyl-RNA linkages [142–144], and peptide bonds [145–147]. Despite this comparatively lower 
abundance, various bond-forming DNAzymes have been reported and will be highlighted in this section. 
3.1. C-C Bond Forming DNAzymes 
The Diels-Alder reaction is an important and versatile reaction in organic chemistry that enables the 
formation of carbon-carbon bonds. The important structural reorganization occurring in the transition 
state of this [4+2] cycloaddition is thought to be central for the recognition by catalytic biomolecules [19]. 
For instance, the first ribozyme with Diels-Alderase activity was evolved by including a UTP equipped 
with a methylpyridyl unit in the selection experiment [140]. The resulting ribozyme catalyzed the 
reaction between an acyclic diene and a maleimide-based dienophile, albeit with a modest efficiency 
(kcat/Km = 237 M−1·min−1). A crystallographic structural investigation revealed that the ribozyme formed 
a hydrophobic pocket which dictates the stereoselective outcome of the reaction as well as the binding 
of the reaction components [148]. After this initial discovery, a more proficient and unmodified 
ribozyme was reported by the laboratory of Jäschke [141]. The resulting ribozyme, 39M49, catalyzed 
the Diels-Alder reaction of maleimide dienophile and an anthracene diene (see Figure 7A) with an 
appreciable efficiency (kcat/Km = 104 M−1·min−1). With the isolation of efficient ribozymes for the Diels-Alder 
reaction, arose the question of whether DNA could equally promote this cycloaddition. In order to 
address this interesting point, Silverman et al. carried out selection experiments using oligonucleotide 
pools that were fully randomized or that bore some sequence similarity to ribozyme 39M49 (i.e., the 36 
nucleotides constituting the randomized region had 70% probability of being identical to 39M49) [149]. 
Both oligonucleotide libraries were asked to catalyze the same Diels-Alder reaction as 39M49, with 
the difference that the maleimide reaction partner was connected to a second maleimide unit in order 
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to the isolation of (RNA) bond-cleaving species due to their potential therapeutic and diagnostic
appeal and the relative ease of selection. This might explain why only a rather restricted number of
bond-forming DNAzymes have been evolved, especially when compared to their RNA surrogates.
Indeed, ribozymes have been evolved to catalyze a variety of bond-forming reactions including
C-C bonds [140,141], aminoacyl-RNA linkages [142–144], and peptide bonds [145–147]. Despite this
comparatively lower abundance, various bond-forming DNAzymes have been reported and will be
highlighted in this section.
3.1. C-C Bond Forming DNAzymes
The Diels-Alder reaction is an important and versatile reaction in organic chemistry that enables
the formation of carbon-carbon bonds. The important structural reorganization occurring in the
transition state of this [4+2] cycloaddition is thought to be central for the recognition by catalytic
biomolecules [19]. For instance, the first ribozyme with Diels-Alderase activity was evolved by
including a UTP equipped with a methylpyridyl unit in the selection experiment [140]. The resulting
ribozyme catalyzed the reaction between an acyclic diene and a maleimide-based dienophile, albeit
with a modest efficiency (kcat/Km = 237 M´1¨min´1). A crystallographic structural investigation
revealed that the ribozyme formed a hydrophobic pocket which dictates the stereoselective outcome
of the reaction as well as the binding of the reaction components [148]. After this initial discovery,
a more proficient and unmodified ribozyme was reported by the laboratory of Jäschke [141]. The
resulting ribozyme, 39M49, catalyzed the Diels-Alder reaction of maleimide dienophile and an
anthracene diene (see Figure 7A) with an appreciable efficiency (kcat/Km = 104 M´1¨min´1). With the
isolation of efficient ribozymes for the Diels-Alder reaction, arose the question of whether DNA could
equally promote this cycloaddition. In order to address this interesting point, Silverman et al. carried
out selection experiments using oligonucleotide pools that were fully randomized or that bore some
sequence similarity to ribozyme 39M49 (i.e., the 36 nucleotides constituting the randomized region
had 70% probability of being identical to 39M49) [149]. Both oligonucleotide libraries were asked
to catalyze the same Diels-Alder reaction as 39M49, with the difference that the maleimide reaction
partner was connected to a second maleimide unit in order to trap the ensuing products rather than
using a biotin moiety as in the ribozyme selection protocol (Figure 7A) [141,149]. Robust catalytic
activities were observed in both selection experiments, and one particular clone (DAB 22) resulting
from the biased library was sequenced. While the exact Michaelis-Menten parameters could not be
obtained for DAB 22, the apparent second-order rate constant (kapp) for the in trans reaction compared
favorably to that of ribozyme 39M49 (0.7 M´1¨ s´1 vs. 0.8 M´1¨ s´1, respectively), suggesting that both
DNA and RNA could catalyze this cycloaddition with similar efficiency.
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Figure 7. Reactions catalyzed by C-C bond-forming DNAzymes. (A) DNAzyme DAB 22 catalyzes the 
Diels-Alder reaction [149]; (B) DNAzyme M14 catalyzes the Friedel-Crafts alkylation reaction [150].  
The Friedel-Crafts alkylation is another synthetically relevant method for the formation of 
carbon-carbon bonds. Although often carried out under strictly anhydrous conditions, Friedel-Crafts 
reactions in water have been reported [151]. Interestingly, a hybrid catalyst consisting of a complex 
of 4,4′-dimethyl-2,2′-bipyridine-Cu2+ and salmon testes DNA was recently shown to be capable of 
promoting an asymmetric Friedel-Crafts alkylation in aqueous medium with high yields and 
enantioselectivities [152]. DNAzymes represent a valuable alternative for the catalysis of Friedel-Crafts 
alkylations due to their single-stranded nature and their catalytic promiscuity. In this context, 
McNaughton et al. set out to identify a DNAzyme that could catalyze this C-C bond forming reaction 
[150]. In the selection setup, an indole moiety was connected to a biotin residue which served in the 
isolation of the catalytically active species (gel-shift), while the other reaction partner, an acyl imidazole, 
was attached to the primer which was used in PCR to generate the randomized library (Figure 7B). 
Application of seven rounds of in vitro selection in the presence of Cu2+ led to the isolation of DNAzyme 
M14 that catalyzed the Friedel-Crafts reaction both in cis and in trans and with appreciable product 
yields (over 70% in 24h). Further bond forming DNAzymes, for instance catalyzing the Michael-addition 
or the aldol reactions, will certainly be reported in the future since precedents exists for RNA [153,154]. 
3.2. Ligation Reactions and Modification of Peptide Substrates 
DNA-mediated catalysis of ligation reactions, i.e., the attack of a nucleophilic group located on 
one substrate on an electrophilic site positioned on another (Figure 8A), is an alluring method for the 
synthesis of various biopolymers [155]. Initial efforts mainly focused on DNA ligation, and shortly after 
the discovery of the first DNAzyme, a DNA catalyst mimicking the activity of the T4 DNA ligase was 
evolved [156]. The Zn2+/Cu2+-dependent DNAzyme E47 was isolated after nine rounds of selection 
and catalyzed the nucleophilic attack of a terminal 5′-hydroxyl group onto a phosphorimidazolide 
unit located at the 3′-end of a second DNA substrate, thus generating a phosphodiester linkage with an 
appreciable rate constant (kcat = 0.07 min−1). More recent selection experiments have led to the isolation 
of DNAzymes capable of self-phosphorylation [157–159], adenylation [160], and ligation [161], 
Figure 7. Reactions catalyzed by C-C bond-forming DNAzymes. (A) DNAzyme DAB 22 catalyzes the
Diels-Alder reaction [149]; (B) DNAzyme M14 catalyzes the Friedel-Crafts alkylation reaction [150].
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The Friedel-Crafts alkylation is another synthetically relevant method for the formation of
carbon-carbon bonds. Although often carried out under strictly anhydrous conditions, Friedel-Crafts
reactions in water have been reported [151]. Interestingly, a hybrid catalyst consisting of a
complex of 4,41-dimethyl-2,21-bipyridine-Cu2+ and salmon testes DNA was recently shown to
be capable of promoting an asymmetric Friedel-Crafts alkylation in aqueous medium with high
yields and enantioselectivities [152]. DNAzymes represent a valuable alternative for the catalysis of
Friedel-Crafts alkylations due to their single-stranded nature and their catalytic promiscuity. In this
context, McNaughton et al. set out to identify a DNAzyme that could catalyze this C-C bond forming
reaction [150]. In the selection setup, an indole moiety was connected to a biotin residue which
served in the isolation of the catalytically active species (gel-shift), while the other reaction partner,
an acyl imidazole, was attached to the primer which was used in PCR to generate the randomized
library (Figure 7B). Application of seven rounds of in vitro selection in the presence of Cu2+ led to
the isolation of DNAzyme M14 that catalyzed the Friedel-Crafts reaction both in cis and in trans and
with appreciable product yields (over 70% in 24 h). Further bond forming DNAzymes, for instance
catalyzing the Michael-addition or the aldol reactions, will certainly be reported in the future since
precedents exists for RNA [153,154].
3.2. Ligation Reactions and Modification of Peptide Substrates
DNA-mediated catalysis of ligation reactions, i.e., the attack of a nucleophilic group located on
one substrate on an electrophilic site positioned on another (Figure 8A), is an alluring method for
the synthesis of various biopolymers [155]. Initial efforts mainly focused on DNA ligation, and
shortly after the discovery of the first DNAzyme, a DNA catalyst mimicking the activity of the
T4 DNA ligase was evolved [156]. The Zn2+/Cu2+-dependent DNAzyme E47 was isolated after
nine rounds of selection and catalyzed the nucleophilic attack of a terminal 51-hydroxyl group onto
a phosphorimidazolide unit located at the 31-end of a second DNA substrate, thus generating a
phosphodiester linkage with an appreciable rate constant (kcat = 0.07 min´1). More recent selection
experiments have led to the isolation of DNAzymes capable of self-phosphorylation [157–159],
adenylation [160], and ligation [161], therefore performing all the steps required for the T4 DNA
ligase-mediated splint ligation of DNA oligonucleotides [29]. A slightly different approach was
employed to isolate DNAzymes capable of ligating two 31- and 51-phosphorylated trinucleotidic
substrates to yield a hexameric DNA sequence with an internal 31-51 pyrophosphate linkage [162].
In this case, a scissile phosphoramidate bond was chosen as the leaving group, which could undergo
a nucleophilic attack by the 51-phosphate unit of one of the trinucleotidic substrates, in analogy to the
catalytic mechanism followed by certain DNA ligases (Figure 8B). The isolated DNAzyme utilized
the 51-phosphorylated trinucleotide as a cofactor and led to a ě103-fold rate enhancement compared
to the uncatalyzed reaction. In addition, a DNAzyme capable of catalyzing the synthesis of branched
DNA has also been isolated: DNAzyme 8LV13 catalyzes the addition of a 21-OH moiety of a single
ribo(adenosine) nucleotide embedded in a DNA oligonucleotide on an electrophilic 51-adenylate
center with high efficiency (kobs = 0.1 min´1) [163].
RNA ligation is of particular interest due to the synthetic challenges inherent to the chemical,
solid-phase synthesis of longer sequences (i.e., >100 nt). The Silverman lab has been particularly
active in the development of RNA-ligating DNAzymes. Comprehensive reviews can be found
on this topic [22,29,164], and only a few key and recent results will be highlighted herein. The
first representative of RNA-ligating DNAzymes, Dz9A5, catalyzed the formation of non-native
21-51-RNA phosphodiester bonds (kobs = 0.013 min´1) by promoting the opening of a 21,31-cyclic
phosphate by a 51-OH group [165]. This initial discovery was shortly followed by the isolation
of DNAzyme 7S11, which specifically recognizes an unpaired adenosine nucleotide on one RNA
substrate and mediates the nucleophilic attack of the 21-hydroxyl group on the α-phosphorous atom
of a 51-triphosphate unit on the other RNA substrate (with a rate of: kobs~0.5 min´1), thus also
generating 21-51 branched RNA linkages [166]. Dz 7S11 and related 21-51 RNA-ligating DNAzymes
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have been employed for the labelling of RNA molecules with a variety of functional groups [167,168]
or for mechanistic investigations [169]. Interestingly, lanthanide cations (Tb3+ particularly), which
often inhibit RNA-cleaving DNAzymes [170], have been shown to massively enhance the catalytic
efficiency of RNA-ligating DNAzymes–most likely by promoting the formation of the catalytically
active structures [171].
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Figure 8. (A) General representation of DNAzyme catalyzed ligation reactions. A nucleophile (e.g., 
an RNA 2′-OH, a terminal 3′-OH, hydroxyl groups of serine and tyrosine, or an amine) located on a 
substrate attacks an electrophilic position (e.g., 5′-triphosphate, 5′-phosphorimidazolide) located on 
the second substrate with the concomitant eviction of a leaving group; (B) Catalyzed ligation reaction 
by hydrolysis of a phosphoramidate bond [162]; (C) DNAzyme catalyzed nucleophilic attack of an 
amine group of a lysine residue on a 5′-phosphorimidazolide unit [172]. 
Figure 8. (A) General representation of DNAzyme catalyzed ligation reactions. A nucleophile (e.g.,
an RNA 21-OH, a terminal 31-OH, hydroxyl groups of serine and tyrosine, or an amine) located on a
substrate attacks an electrophilic position (e.g., 51-triphosphate, 51-phosphorimidazolide) located on
the second substrate with the concomitant eviction of a leaving group; (B) Catalyzed ligation reaction
by hydrolysis of a phosphoramidate bond [162]; (C) DNAzyme catalyzed nucleophilic attack of an
amine group of a lysine residue on a 51-phosphorimidazolide unit [172].
For synthetic purposes and with the aim of expanding the chemical nature of accessible
substrates, catalytic nucleic acids that function in organic media would represent a valuable tool.
While some small ribozymes such as the hammerhead ribozyme have been shown to accommodate
reasonably well to media containing organic co-solvents [173], RNA-cleaving DNAzymes such
as Dz8-17 are rather reluctant to operate under such conditions [174]. Rather serendipitously, an
RNA-ligase DNAzyme was identified in a selection experiment that can operate in the presence of
various organic co-solvents [175]. This behavior was then found to be rather general for RNA-ligating
DNAzymes, since two other catalysts still showed appreciable ligation activity in media containing
high concentrations of organic co-solvents (e.g., kobs values of 0.1 min´1 were observed for media
containing up to 50% EtOH).
The catalysis of the ligation of nucleic acid-based substrates is of importance for biochemical
and biotechnological applications since this represents a valid alternative to splint ligations and
to solid-phase synthesis. In addition, Watson-Crick base-pair interactions between oligonucleotide
substrates and DNAzymes obliterate the need for allocating additional energy to binding the
substrate to the enzyme. These reasons account for the intense research efforts that focused on the
fabrication of catalytic nucleic acids capable of ligating oligonucleotides together. On the other hand,
the inclusion of non-oligonucleotide substrates in selection experiments could broaden the scope and
increase the synthetic usefulness of DNAzymes. In this context, the Silverman laboratory developed
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numerous DNAzymes capable of recognizing and modifying peptide substrates [136]. In a seminal
contribution, DNAzymes were evolved to catalyze the nucleophilic attack of hydroxyl groups located
on the side-chain of a tyrosine (DNAzyme Tyr1, kobs = 0.06 min´1) unit embedded in a DNA substrate
on a 51-triphosphate unit on an RNA substrate, resulting in the formation of RNA-nucleopeptide
linkages [176]. This catalytic activity was then expanded to other side-chains (e.g., serine [177] or
phosphorylated tyrosine [178]), non-nucleosidic substrates (mainly consisting of tri- or hexapeptides
embedded in DNA oligonucleotides) and for the phosphorylation of peptide substrates [179].
Surprisingly, DNAzymes could not compensate for the apparently lower nucleophilicity of the
NH2 functionality of the side-chain of lysine and the 51-triphosphate had to be replaced by a more
electrophilic 51-phosphorimidazolide (51-Imp) unit to enable a positive outcome of the selection
experiments (Figure 8C) [175]. In this context, a particular DNAzyme, 9DT105, was isolated from one
of these in vitro selections and was shown to ligate the terminal amino group of the lysine substrate
to the 51-Imp-modified substrate with an appreciable efficiency (kobs = 1.7 ˆ 10´3 min´1; 50% yield).
Undoubtedly, the diversity of the nature of the substrates accepted by DNAzymes as well as
their activities are both constantly increasing and the isolation of catalytic species capable of more
complex operations on larger peptides or even proteins seems to be imminent.
4. DNAzymes Catalyzing other Reactions
As aforementioned, DNAzymes capable of recognizing and utilizing non-nucleosidic substrates
in general, and small molecules particularly, are rather scarce. However, an important example
is DNAzyme PS5.ST1 which mimics the action of chelatases by inserting metal cations (Zn2+ or
Cu2+) into porphyrin scaffolds (Figure 9A) [180]. A key step in the isolation of Dz PS5.ST1 was
to challenge a very long (N228) randomized oligonucleotide population to bind to a bead-bound,
constrained porphyrin that mimicked the transition state adopted in the active site of chelatases [181].
The resulting aptamers, which bound to various porphyrin substrates with low-micromolar affinities,
were then tested for their capacity at catalyzing the insertion of M2+ cations into mesoporphyrin
IX [180]. One particular aptamer coined DzPS5.ST1, inserted Cu2+ into MPIX with a catalytic
efficiency of 79 min´1¨M´1 which represents a ~1400-fold enhancement compared to the uncatalyzed
background reaction. An optimization of the sequence by rational design and improvement
of the reaction conditions made it possible to identify a shortened and highly proficient
(kcat/Km = 3.3 ˆ 104 min´1¨M´1) version (PS5.M) of the initial DNAzyme [182]. Following the
discovery and optimization of DzPS5.ST1 as a porphyrin metalation catalyst, its function was
extended to the role as a highly efficient peroxidase mimic [183]. Indeed, the metalated porphyrin
hemin (Figure 9B) was found to tightly bind to DNAzyme PS5.M and by the same token to act
as a potent inhibitor of the metalation reaction. On the other hand, when hemin was complexed
to DzPS2.M—another aptamer isolated in the initial selection experiment (vide supra)—in the
presence of a detergent (to avoid aggregation and µ-oxo dimer formation) and hydrogen peroxide,
ABTS was oxidized to the corresponding radical cation ABTS‚+ (Figure 9C) with a rate constant
~250-fold superior to that of the hemin-mediated background reaction. Similarly to peroxidases
such as the horseradish peroxidase, DzPS2.M can oxidize a variety of substrates including luminol
(Figure 9C) [184] or NADH [185] which then serve as indicators for the progress of the reaction.
Due to these favorable properties, this peroxidase mimic has found numerous applications essentially
in the field of biosensing, DNA detection, and structural investigations [186–189]. Interestingly, a
variant of DzPS2.M was conjugated with polyethylene glycol (PEG) units and shown to maintain the
peroxidase activity in methanol -representing the first example of a DNAzyme capable of working in
completely organic media [173]. More recently, DNAzyme PS2.M was appended at the C5 position
of the nucleobase of a dUTP and incorporated into DNA by primer extension reactions mediated by
the KF exo´ DNA polymerase [190]. This ingenious system was then employed for the naked eye
detection of point mutations, particularly the T1796A substitution in the B type Raf kinase gene.
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As for most DNAzymes, the exact mechanism has not been fully elucidated so far. However,
it is believed that the G-quadruplex nature of the DNAzyme offers a hydrophobic binding site for
the hemin cofactor [183,191]. Following binding of the hemin inside of the G-quadruplex region,
the axial chlorine is displaced by an H2O2 molecule which is then cleaved in a process presumably
mediated by a guanine nucleotide [188]. Loss of a water molecule then leads to the oxidation of
the iron(III) prosthetic group to the highly reactive, hemin-bound radical cation porph:Fe(IV)=O‚+,
which in turn withdraws one electron from the ABTS substrate to form both the ABTS‚+ product
and a more stable intermediate, ferryl-hemin (porph:Fe(IV)=O) [188,192]. After this one electron
transfer, the ferryl-hemin moiety abstracts another electron from a second H2O2 molecule, which then
leads to the formation of a ferric-superoxy (porph:Fe(III)-O2‚´) intermediate. Finally, interaction of
this ferric-superoxy species with a second ABTS substrate molecule eventually restores the initial
hemin:iron(III) complex [188].
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Figure 9. (A) Porphyrin metalation catalyzed by DNAzyme PS5.ST1 (M = Zn2+ or Cu2+) with 
mesoporphyrin IX (MPIX) as a substrate [180]; (B) Chemical structure of the hemin (Fe(III)-protoporphyrin 
IX) cofactor; (C) Reactions catalyzed by the DNAzyme PS2.M with hemin: reaction of luminol with 
hydrogen peroxide to yield the corresponding diacid and chemiluminescence [183,193]; oxidation of the 
chromogenic ABTS (2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)) to the corresponding radical 
cation ABTS+ which has a distinctive green color [193]. 
Figure 9. (A) Porphyrin metalation catal zed by DNAzyme PS5.ST1 (M = Zn2+ or
Cu2+) with mesoporphyrin IX (MPIX) as a substrate [180]; (B) Chemical structure
of the hemin (Fe(III)-protoporphyrin IX) cofactor; (C) Reactions catalyzed by t e
DNAzyme PS2.M with min: reaction of luminol with hydrog n peroxide to yield the
correspo ding diacid nd chemilumin scence [183,193]; oxidation f the chromogenic ABTS
(2,21-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)) to the corresponding radical cation ABTS‚+
which has a distinctive green color [193].
5. Toward an Expansion of the Catalytic Repertoire of DNAzymes
Most known DNAzymes require one or multiple cofactors (usually divalent metal cations)
for optimal activity, and this often at concentrations that exceed those found in cells. A further
caveat is that DNAzymes, like all unmodified functional nucleic acids, are prone to nuclease
degradation, which is clearly detrimental for certain (in vivo) applications. In addition, some reactions
such as amide bond cleavage seem to be inaccessible to catalytic nucleic acids, probably due to
the lack of suitable functional groups [135,136,194]. Thus, in order to mitigate these drawbacks,
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DNAzymes can be equipped with non-natural functional groups (Figure 10), either during or after
the selection process [78,195,196]. The inclusion of modifications directly into the selection process via
the co-polymerization of dN*TPs [197,198] offers the advantages of providing (i) optimized catalytic
systems that do not need much further optimization; (ii) an additional dimension—i.e., chemical
space—that can be explored during selection experiments; (iii) a facile modulation of the nature of
the functional groups involved. This strategy was first successfully applied to generate modified
aptamers with enhanced properties and was later hijacked for the generation of DNAzymes [14,15].
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Figure 10. Chemical structures of modified nucleoside triphosphates (dN*TPs) used in in vitro 
selection experiments for the generation of modified DNAzymes: C5-imidazole-functionalized dUTP 
(1), dAimTP (2), dCaaTP (3), dUgaTP (4), FANA-NTPs (5), and HNA-NTPs (6). The chemical modifications 
are highlighted in red. 
The first reported DNAzyme obtained by the inclusion of a dN*TP in the in vitro selection process 
was Dz16.2-11 (Figure 11A) [199]. This Zn2+-dependent RNA-cleaving DNAzyme contains modified 
dUMP (1) units (Figure 10) and hydrolyzes all-RNA substrates with a very high catalytic efficiency 
(kcat/Km~108 min−1·M−1), presumably via a mechanism reminiscent of enzymes such as carboxypeptidase A. 
Paralleling the discovery of Dz16.2-11, other selection experiments involving up to three dN*TPs 
used in lieu of their natural counterparts focused on trying to obliterate the need for M2+ cofactors for 
RNA-cleavage [68,200–204]. A first example was reported by Perrin et al. who used the combination of 
triphosphates bearing histidine- (dAimTP (2)) and lysine-like (C5-allyamino-dUTP, dUaaTP) side-chains 
to generate a ribonuclease mimic promoting the M2+-independent cleavage of RNA substrates with 
high efficiency (kcat/Km = 5 × 105 min−1·M−1) [205,206]. In both examples, the imidazole units play a 
fundamental role, either as chelators of Zn2+ or in participating in general acid/general base catalysis. 
Additionally, the pKa of imidazole residues appended on nucleobases has recently been shown to be 
variable depending on the nature of the interaction with the DNA context [207]. 
With the intent of further increasing the catalytic efficiency and broadening the substrate scope 
of M2+-independent DNAzymes, a third, guanidinium-modified dN*TP was included in selection 
experiments. Indeed, modified oligonucleotide populations obtained by the co-polymerization of the 
dN*TPs (2), (3), and (4) were challenged to cleave substrates containing either a single embedded scissile 
Figure 10. Chemical structures of modified nucleoside triphosphates (dN*TPs) used in in vitro
selection experiments for the generation of modified DNAzymes: C5-imidazole-functionalized dUTP
(1), dAimTP (2), dCaaTP (3), dUgaTP (4), FANA-NTPs (5), and HNA-NTPs (6). The chemical
modifications are highlighted in red.
The first reported DNAzyme obtained by the inclusion of a dN*TP in the in vitro selection
process was Dz16.2-11 (Figure 11A) [199]. This Zn2+-dependent RNA-cleaving DNAzyme contains
modified dUMP (1) units (Figure 10) and hydrolyzes all-RNA substrates with a very high catalytic
efficiency (kcat/Km~108 min´1¨M´1), presumably via a mechanism reminiscent of enzymes such as
carboxypeptidase A.
Paralleling the discovery of Dz16.2-11, other selection experiments involving up to three dN*TPs
used in lieu of their natural counterparts focused on trying to obliterate the need for M2+ cofactors
for RNA-cleavage [68,200–204]. A first example was reported by Perrin et al. who used the
combination of triphosphates bearing histidine- (dAimTP (2)) and lysine-like (C5-allyamino-dUTP,
dUaaTP) side-chains to generate a ribonuclease mimic promoting the M2+-independent cleavage of
RNA substrates with high efficiency (kcat/Km = 5 ˆ 105 min´1¨M´1) [205,206]. In both examples,
the imidazole units play a fundamental role, either as chelators of Zn2+ or in participating in general
acid/general base catalysis. Additionally, the pKa of imidazole residues appended on nucleobases
has recently been shown to be variable depending on the nature of the interaction with the DNA
context [207].
With the intent of further increasing the catalytic efficiency and broadening the substrate
scope of M2+-independent DNAzymes, a third, guanidinium-modified dN*TP was included
in selection experiments. Indeed, modified oligonucleotide populations obtained by the
co-polymerization of the dN*TPs (2), (3), and (4) were challenged to cleave substrates containing
either a single embedded scissile ribo(cytosine)phosphodiester linkage (Figure 11B) or a stretch of
RNA nucleotides (Figure 11C) in the exclusion of M2+. The resulting DNAzymes, Dz9-86 [202]
and Dz12-91 [204], respectively, could cleave their respective substrates with high first-order rate
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constants (kobs = 0.13 min´1 and 0.06 min´1) at 37 ˝C in the absence of metal cofactors. Surprisingly,
both DNAzymes are very similar both in terms of sequence composition and topology despite having
been selected for rather different substrates. Thus, it appears that minute alterations in the catalytic
core account for the higher catalytic efficiency of Dz12-91 compared to Dz9-86. Indeed, the rate
constants for self-cleavage observed for Dz12-91 were higher than those for Dz9-86 regardless of the
nature of the substrate (0.13 vs. 0.0014 min´1 for all-RNA and kobs = 0.27 min´1 vs. 0.13 min´1 for the
substrate with the single ribo(cytosine) nucleotide, respectively).
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More recently, engineered polymerases [208] that enable the replication of xeno-nucleic acids XNAs 
with sugar-altered structures were used in selection experiments to generate XNAzymes [209,210]. 
Four types of XNA chemistries, including FANAs (5) and HNAs (6), were used to fabricate all-RNA 
cleaving XNAzymes [210]. The most efficient catalyst, FANAzyme FR17_6 (Figure 11D), hydrolyzed 
an all-RNA substrate with an appreciable rate constant and with multiple turnover (kobs = 0.026 min−1; 
35 turnovers in 96 h). Interestingly, while all these XNAzymes were novel sequences, some topological 
similarities with the DNAzymes 8-17 and 10-23 were observed, suggesting that each selection scheme 
might have a limited subset of answers to the particular reaction it is challenged to undertake. 
Furthermore, XNAzymes capable of ligating two RNA substrates were obtained by application of a 
selection protocol devised for unmodified DNA (Figure 8A). Even though the most efficient XNA 
ligase (based on FANA chemistry) catalyzed the ligation of the two substrates with a rather low rate 
constant (kobs = 2 × 10−4 min−1), the rate enhancement compared to the uncatalyzed reaction is substantial 
(~104). Finally, a FANAzyme could also be selected to ligate two FANA substrates (kobs = 0.04 min−1) 
and the synthetic usefulness of this XNAzyme was underscored by generating a 100 nt long FANA 
oligonucleotide. 
A large variety of dN*TPs, equipped with amino acid-like residues as well as non-natural 
functional groups, have been developed for their use in in vitro selection experiments to generate 
DNAzymes with an expanded catalytic repertoire [135,136,198,211–216]. However, no further modified 
DNAzymes have been reported so far. 
Figure 1. Sequences and hypothetical 2D structures of DNAzymes obtained with dN*TPs included
in the in vitro selections: Dz16.2- 1 (A), Dz9-86 (B), Dz12-91 (C), and FANAzyme FR17_6 (D). The
bold red letters highlight the position of the modifications while a rows indicate the cleavage sites.
More recently, engineered polymerases [208] that enable the replication of xeno-nucleic
acids XNAs with sugar-altered structures were used in selection experiments to generate
XNAzymes [209,210]. Four types of XNA chemistries, including FANAs (5) and HNAs (6), were
used to fabricate all-RNA cleaving XNAzymes [210]. The most efficient catalyst, FANAzyme FR17_6
(Figure 11D), hydrolyzed an all-RNA substrate with an appreciable rate constant and with multiple
turnover (kobs = 0.026 min´1; 35 turnovers in 96 h). Interestingly, while all these XNAzymes
were novel sequences, some topological similarities with the DNAzymes 8-17 and 10-23 were
observed, suggesting that each selection scheme might have a limited subset of answers to the
particular reaction it is challenged to undertake. Furthermore, XNAzymes capable of ligating two
RNA substrates were obtained by application of a selection protocol devised for unmodified DNA
(Figure 8A). Even though the most efficient XNA ligase (based on FANA chemistry) catalyzed the
ligation of the two substrates with a rather low rate constant (kobs = 2 ˆ 10´4 min´1), the rate
enhancement compared to the uncatalyzed reaction is substantial (~104). Finally, a FANAzyme could
also be selected to ligate two FANA substrates (kobs = 0.04 min´1) and the synthetic usefulness of this
XNAzyme was underscored by generating a 100 nt long FANA oligonucleotide.
A large variety of dN*TPs, equipped with amino acid-like residues as well as non-natural
functional groups, have been developed for their use in in vitro selection experiments to generate
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DNAzymes with an expanded catalytic repertoire [135,136,198,211–216]. However, no further
modified DNAzymes have been reported so far.
6. Conclusions and Outlook
Since their recent advent, DNAzymes have grown into a very potent type of functional
nucleic acids with ramifications into multiple applications including therapeutics, biosensing, DNA
nanotechnology, and organic synthesis. The over 20 different chemical transformations catalyzed by
DNAzymes summarized herein are a testimony for the growing importance of these biocatalysts.
Even though DNAzymes are still rather weak rivals for their proteinaceous and to a certain extent
their RNA counterparts [217], progress made in the development of these DNA-based catalysts
cannot be overlooked: diffusion-controlled catalytic efficiencies have been achieved for RNA-cleaving
DNAzymes under specific (high [M2+]) conditions and DNAzymes have recently been evaluated in
clinical trials for the treatment of skin cancer and asthma. However, despite numerous favorable
assets, DNAzymes are not quite ready for a general use in practical applications and some challenges
need to be overcome: firstly, the catalytic efficiencies (kcat/Km values) regularly lie below the
standards required for in vivo applications. Secondly, the strong M2+-dependence for optimal catalytic
activity might also result in a predicament for cellular assays since the concentrations of free M2+ in
cells are usually well below the levels required by the DNAzymes (e.g., free [Zn2+] and [Mn2+] lie
in the high picomolar [218] and low micromolar [219] range, respectively). Thirdly, mechanistic and
structural studies are required to gain a better understanding of the mode of action of DNAzymes
and possibly enable their rational design. Lastly, some potentially useful reactions (e.g., amide
bond cleavage, Michael-addition reaction, organocatalysis . . . ) still elude DNAzymes and both the
selectivity and recognition of non-oligonucleotide substrates such as peptides and small organic
compounds still need to be improved. In this context, the combination of Darwinian evolution, the
robustness of the DNA scaffold, and the possible inclusion of a broad array of additional functional
groups will be pivotal to circumvent these limitations, while the development of new selection
strategies will also greatly contribute to facilitate the selection process leading to the fabrication of
DNAzymes [220].
Taken together, DNAzymes represent a very valuable addition to the armamentarium of
existing biocatalysts and have made an important step out of infancy. Their chemical repertoire is
continuously increased as well as their efficiencies. Progress in selection strategies will certainly help
in the development of DNAzymes with hitherto unknown reactivity for their further use in practical
applications. Particularly, future efforts should be invested in the development of DNAzymes capable
of selectively recognizing proteins and carbohydrates for their further processing since they would
represent invaluable biological and synthetic tools.
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Abbreviations
cis/trans catalyst: intra-/inter- molecular catalyst; dinucleotide junction: bases immediately flanking
the scissile bond; dN*TPs: modified nucleoside triphosphates; Dz: DNAzyme, deoxyribozyme, or
DNA enzyme; nt: nucleotide; SELEX: systematic evolution of ligands by exponential enrichment;
ssDNA or ssRNA: single-stranded DNA or RNA, respectively; 51-Imp: 51-phosphorimidazolide;
FANA: 21-deoxy-21-fluoro-β-D-arabinonucleic acid; XNA: xeno-nucleic acids.
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